Fortune's Fastest Growing Companies
Our annual collection of rising phenoms reveals who - and what - is succeeding even in a stagnant economy.
1. SXC Health Solutions
SXC Health Solutions
3-year average
Revenue Growth: 151%
Profit Growth: 65%
Total Return: 105%

SXC is both a pharmacy benefits manager (PBM) and a service provider to PBMs. With some $72 billion in branded drugs losing patent protection in the next five years, sales of generic alternatives are likely to rise. SXC's PBM unit, which acts as middleman between the insurance company and the pharmacy, could be the beneficiary: It makes more money each time a person uses a generic drug rather than a branded drug. Health care reform also means more people will be covered by Medicaid, which could benefit both of SXC's business lines.

SXC also stands to gain from the growth in the use of specialty drugs like those for rheumatoid arthritis. SXC expanded its contract with one of its clients, HealthSpring, which focuses on specialty drugs, and acquired MedFusionRX, a specialty pharmacy provider, in December.

By Betsy Feldman and Anne VanderMey with Josh Dawsey and Sam Silverman

From the September 26, 2011 issue.

Revenue and profit figures reflect the four quarters through first-quarter 2011.
Total return is through June 30, 2011.
Fastest Growing: All-stars
Fastest Growing: Top Tech
Fastest Growing: Full List